Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Paul Daruwala, chief operating officer, and James Levine, chief financial officer of Cidara are scheduled to participate in 1×1 meetings with investors at the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies, which takes place on September 23, 2019, and that Jeffrey Stein, Ph.D., president and chief executive officer of Cidara will present at the 2019 Cantor Global Healthcare Conference, which takes place October 2-4, 2019.? Both conferences will take place in New York City.? The details of Cidara?s participation at these conferences is as follows: